Gonapeptyl Cr Ampoule 3.75Mg 1 PC

1 prefilled syringe with 172 mg controlled - release microcapsules and 1 prefilled syringe with solvent

Children: Treatment of confirmed central precocious puberty (girls under 9 years, boys under 10 years).
Women:
- Preoperative reduction of myoma size to reduce the symptoms of bleeding and pain in women with symptomatic uterine myomas.
- In assisted reproduction techniques to prevent premature LH surges.
- Symptomatic uterine myomas; when suppression of the ovarian hormonogenesis is indicated as a preoperative measure to reduce the size of individual myomas prior to scheduled myoma nucleation or hysterectomy.
- Symptomatic endometriosis confirmed by laparoscopy; when suppression of the ovarian hormonogenesis is indicated to the extent that surgical therapy is not primarily indicated.
Men: Treatment of advanced, hormone-dependent prostate carcinoma.